Skip to main content
Midas Edge

cbdMD Inc

For the period ended Dec 31, 2024. Filed Feb 13, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Dec 31, 2024 · Filed Feb 13, 2025

YCBD$0.38-8.4%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

ITEM 6. Exhibits

Incorporated by Reference · Filed or Furnished
No. · Exhibit Description · Form · Date Filed · Number · Herewith
2.1Merger Agreement dated December 3, 2018 by and among Level Brands, Inc., AcqCo, LLC, cbdMD LLC and Cure Based Development, LLC8-K12/3/182.1
2.2Articles of Merger dated December 20, 2018 as filed with the Secretary of State of Nevada merging AcqCo, LLC with and into Cure Based Development, LLC10-Q2/14/192.2
2.3Articles of Merger dated December 20, 2018 as filed with the Secretary of State of North Carolina merging AcqCo, LLC with and into Cure Based Development, LLC10-Q2/14/192.3
2.4Articles of Merger dated December 20, 2018 as filed with the Secretary of State of Nevada merging Cure Based Development, LLC with an into cbdMD LLC10-Q2/14/192.4
2.5Articles of Merger dated December 20, 2018 as filed with the Secretary of State of North Carolina merging Cure Based Development, LLC with an into cbdMD LLC10-Q2/14/192.5
2.6Addendum No. 1 to Agreement and Plan of Merger dated March 31, 20218-K4/1/2110.1
3.1Articles of Incorporation1-A9/18/172.1
3.2Articles of Amendment to the Articles of Incorporation – filed April 22, 20151-A9/18/172.2
3.3Articles of Amendment to the Articles of Incorporation – filed June 22, 20151-A9/18/172.3
3.4Articles of Amendment to the Articles of Incorporation – filed November 17, 20161-A9/18/172.4
3.5Articles of Amendment to the Articles of Incorporation – filed December 5, 20161-A9/18/172.5
3.6Articles of Amendment to Articles of Incorporation8-K4/29/193.7
3.7Articles of Amendment to the Articles of Incorporation including the Certificate of Designations, Rights and Preferences of the 8.0% Series A Cumulative Convertible Preferred Stock8-A10/11/193.1(f)
3.8Articles of Amendment of Articles of Incorporation, as amended, of cbdMD, Inc. effective April 24, 2023 - reverse stock split8-K4/27/233.1
3.9Bylaws, As amended1-A9/18/172.6
31.1Certification of Principal Executive Officer and Principal Financial Officer (Section 302)Filed
32.1Certification of Principal Executive Officer and Principal Financial Officer (Section 906)Furnished*
101.INSInline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL documentFiled
101.SCHInline XBRL Taxonomy Extension Schema DocumentFiled
101.CALInline XBRL Taxonomy Extension Calculation Linkbase DocumentFiled
101.DEFInline XBRL Taxonomy Extension Definition Linkbase DocumentFiled
101.LABInline XBRL Taxonomy Extension Label Linkbase DocumentFiled
101.PREInline XBRL Taxonomy Extension Presentation Linkbase DocumentFiled
104Cover Page Interactive Data File (embedded within the Inline XBRL Document and include in Exhibit 101)Filed
  • Exhibits and/or schedules have been omitted. The Company hereby agrees to furnish to the staff of the Securities and Exchange Commission upon request any omitted information.
  • This exhibit is being furnished rather than filed and shall not be deemed incorporated by reference into any filing, in accordance with Item 601 of Regulation S-K.

Copies of this report (including the financial statements) and any of the exhibits referred to above will be furnished at no cost to our stockholders who make a written request to our Corporate Secretary at cbdMD, Inc. 2101 Westinghouse Blvd, Suite A, Charlotte, NC 28273.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf signed on the registrant’s behalf by a duly authorized officer of the registrant and by the principal financial or chief accounting officer of the registrant.

cbdMD, INC.
February 13, 2025By:/s/ T. Ronan Kennedy
T. Ronan Kennedy, Chief Executive Officer and
principal executive officer
February 13, 2025By:/s/ T. Ronan Kennedy
T. Ronan Kennedy, Chief Financial Officer and
principal financial officer
February 13, 2025/s/ Brad Whitford
Brad Whitford, Chief Accounting Officer
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.